Pipeline
Our pipeline for developing highly innovative solutions.
We continuously improve our pipeline so that we can make ongoing innovations to our therapeutic areas.
| Molecule/Project | Research | Innovation | Clinical research | Registers |
|---|---|---|---|---|
| Bilaxten Minus 6 | ||||
| Bilaxten ODT 20mg | ||||
| Tealaxten Paediatric | ||||
| Claversal 1500 tablets | ||||
| Claversal granules | ||||
| Claversal 500 Canada | ||||
| Hidroferol weekly | ||||
| Boneferol | ||||
| Osavit-D | ||||
| Robaxin 1.5g | ||||
| Hemorrane Plus | ||||
| Robaxixel Granules |
Last update March 2023
It is progressing as planned and the conditions approved in the IC are maintained (potential and expenditure)
Delay > 6 months or changes with respect to what was approved in the IC
Delay > 6 months and changes with respect to what was approved in the IC
